Top Markets
Coin of the day
Imagion Biosystems Limited Imagion Biosystems Limited

Imagion Biosystems Limited

IBX
株式のランク #35262
Imagion Biosystems Limited operates as a medical imaging company that uses... Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
株価
$0.00775813
最終同期: 2026-08-14
時価総額
$4.19M
変化(1日)
-15.38%
変化(1年)
-20.49%
AU
取引 Imagion Biosystems Limited (IBX)

カテゴリー

Imagion Biosystems Limited(IBX)の配当利回りの履歴
Imagion Biosystems Limited(銘柄コード: IBX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Imagion Biosystems Limited(IBX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)